{
    "nctId": "NCT05571618",
    "briefTitle": "The Rechallenge of ADCs in MBC Patients",
    "officialTitle": "A Multicenter, Real-world Study of the Efficacy and Safety of Antibody-drug Conjugates (ADCs) Rechallenge in Patients with Prior Exposure to ADCs Metastatic Breast Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "PFS",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* age \\> 18 years old.\n* Diagnosed with Metastatic Breast Cancer.\n* Patients with prior exposure to ADC (either in the adjuvant setting or metastatic disease are allowed).\n* Patients plan to or have received ADCs for the second or more time.\n* Complete medical history was available.\n\nExclusion Criteria:\n\n* Medical history was incomplete",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}